Clinical Trials Directory

Trials / Completed

CompletedNCT01878838

The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.

A Prospective Randomized Controlled Clinical Trial Comparing the Intra-operative Effects, Safety, Efficacy and Performance of Two Commercially Available Laser Systems in Patients Undergoing Femtosecond Laser-Assisted Cataract Surgery.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Steven H. Linn, OD · Academic / Other
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

This study compares two FDA approved Cataract Lasers.

Detailed description

The purpose of this study is to systematically evaluate the performance of two commercially available and FDA cleared femtosecond laser systems in patients undergoing femtosecond laser-assisted cataract surgery. Objective data on the repeatability and accuracy of the studied parameters will be gathered and reported as endpoints of the study. The two systems studied are the Catalys™ Precision Laser System (OptiMedica, CA, USA) and the LenSx® Laser System (Alcon Laboratories, Inc., Fort Worth, TX). Published data have suggested that the femtosecond laser is a useful tool for cataract surgery. This study is to determine whether differences or similarities exist in specific treatment parameters achieved with two FDA cleared and commercially available femtosecond laser cataract surgery platforms

Conditions

Interventions

TypeNameDescription
PROCEDUREFemtosecond Laser Assisted Cataract Surgery w/ Catalys LaserCohort subjects will undergo Femtosecond Laser Assisted Cataract Surgery in both eyes, with the Optimedica Catalys laser on one eye, and the Alcon LensX laser on the other. First eyes will be randomized.
PROCEDUREFemtosecond Laser Assisted Cataract Surgery w/ LenSx LaserCohort subjects will undergo Femtosecond Laser Assisted Cataract Surgery in both eyes, with the Optimedica Catalys laser on one eye, and the Alcon LensX laser on the other. First eyes will be randomized.

Timeline

Start date
2013-04-01
Primary completion
2013-12-01
Completion
2014-01-01
First posted
2013-06-17
Last updated
2025-03-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01878838. Inclusion in this directory is not an endorsement.